Company Accounts and Tax Online 15115843 Board of Directors 5.9.23 30.9.24 30.9.24 No description of principal activity false iso4217:GBP xbrli:pure 15115843 2024-09-30 15115843 2023-09-05 2024-09-30 15115843 countries:EnglandWales 2023-09-05 2024-09-30 15115843 curr:PoundSterling 2023-09-05 2024-09-30 15115843 uk-bus:PrivateLimitedCompanyLtd 2023-09-05 2024-09-30 15115843 uk-bus:Micro-entities 2023-09-05 2024-09-30 15115843 uk-bus:AuditExempt-NoAccountantsReport 2023-09-05 2024-09-30 15115843 uk-bus:FullAccounts 2023-09-05 2024-09-30 15115843 uk-bus:RegisteredOffice 2023-09-05 2024-09-30 15115843 uk-bus:Director1 2023-09-05 2024-09-30 15115843 uk-bus:Director1 2023-09-05 15115843 uk-bus:Director1 2024-09-30 15115843 core:AfterOneYear 2024-09-30 15115843 core:WithinOneYear 2024-09-30 15115843 core:WithinOneYear 2023-09-05 2024-09-30 15115843 core:AfterOneYear 2024-09-30 15115843 core:AfterOneYear 2023-09-05 2024-09-30 15115843 core:ShareCapital 2024-09-30 15115843 core:RevaluationReserve 2024-09-30 15115843 core:RetainedEarningsAccumulatedLosses 2024-09-30 15115843 1 2023-09-05 2024-09-30

# DR. ADAMS PHARMACEUTICALS LTD

## Company Registration Number:
15115843 (England and Wales)

## Unaudited micro entity accounts for the year ended 30 September 2024

## Period of accounts

## Start date: 05 September 2023

## End date: 30 September 2024

# DR. ADAMS PHARMACEUTICALS LTD

## Contents of the Financial Statements

for the Period Ended 30 September 2024

Company Information - 3 |
Profit and Loss Account - 4 |
Balance sheet - 5 |
Footnotes to the Balance Sheet - 7 |

# DR. ADAMS PHARMACEUTICALS LTD

## Company Information

for the Period Ended 30 September 2024

Registered office: |  | 128 City Road London GBR EC1V 2NX
Company Registration Number: |  | 15115843 (England and Wales)

# DR. ADAMS PHARMACEUTICALS LTD

## Profit and Loss Account

for the Period Ended 30 September 2024

| 13 months to 30 Sep 2024 £
--- | ---
Turnover | 47,884
Income from coronavirus (COVID-19) business support grants | 0
Other Income | 0
Cost of Materials | ( 42,724 )
Staff Costs | ( 0 )
Depreciation and Writeoffs | ( 0 )
Other charges | ( 16,746 )
Tax on Profit | ( 0 )
Profit or (Loss) for Period | ( 11,586 )

# DR. ADAMS PHARMACEUTICALS LTD

## Balance sheet

As at 30 September 2024

| 13 months to 30 Sep 2024 £
--- | ---
Called up share capital not paid: | 0
Fixed Assets: | 0
Current assets: | 60,320
Prepayments and accrued income: | 0
Creditors: amounts falling due within one year: | ( 71,906 )
Net current assets (liabilities): | ( 11,586 )
Total assets less current liabilities: | ( 11,586 )
Creditors: amounts falling due after more than one year: | ( 0 )
Provision for liabilities: | ( 0 )
Accruals and deferred income: | ( 0 )
Total net assets (liabilities): | ( 11,586 )
Capital and reserves: | ( 11,586 )

# DR. ADAMS PHARMACEUTICALS LTD

## Balance sheet continued

For the year ending 30 September 2024 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared and delivered in accordance with the provisions of the small companies regime applicable to micro-entities.

This report was approved by the board of directors on 9 March 2026
And Signed On Behalf Of The Board By:

Name: Zhengjie Wang
Status: Director

The notes form part of these financial statements

# DR. ADAMS PHARMACEUTICALS LTD

## Footnotes to the Financial Statements

for the Period Ended 30 September 2024

- ## 1. Employee Information

  Average number of employees: 0

# DR. ADAMS PHARMACEUTICALS LTD

## Footnotes to the Financial Statements

for the Period Ended 30 September 2024

- ## 2. Off balance sheet disclosure

  No